Technology | July 07, 2014

Vital Connect HealthPatch MD Biosensor Receives FDA Clearance


July 7, 2014 — Vital Connect announced its HealthPatch MD biosensor has received U.S. Food and Drug Administration (FDA) clearance. The solution is capable of capturing clinical-grade biometric measurements and is the first FDA-cleared medical device that includes a fall detection feature. Designed to support the treatment of a range of diseases and conditions, the HealthPatch MD is a versatile and comprehensive biosensor solution that may be used by healthcare professionals to provide 24-hour, real-time, unattended monitoring of patients’ physiological data or vital signs.

Combined with Vital Connect’s proprietary algorithms, the sensor’s technologies enable the device to provide clinical-grade measurements of the following core health metrics: single-lead ECG (electrocardiogram), heart rate, heart rate variability, respiratory rate, skin temperature, posture including fall detection and severity, and steps. The HealthPatch MD leverages on-board intelligence to perform sophisticated, proprietary SensorFusion algorithms, which process thousands of data points per minute to produce accurate robust measurements.

“We are very proud and excited that the HealthPatch MD has received FDA clearance and can now be sold in the United States for medical use,” said Vital Connect CEO Nersi Nazari. “Together with our partners, we cannot wait to begin implementing solutions using the HealthPatch MD to optimize the way healthcare is delivered in the U.S.”

Healthcare professionals will be able to use the sensor to collect patient data on demand and may be notified when physiological data falls outside selected parameters. The HealthPatch MD is intended to be less obtrusive than other sensors, can be customized for data reporting, operates on Bluetooth 4.0 and provides HIPPA-compliant cloud-based storage and connectivity.

The HealthPatch MD has received regulatory approval (CE mark) for distribution in the European Union, and is licensed and registered by Health Canada for distribution in Canada.

For more information: www.vitalconnect.com


Related Content

News | ECG

November 21, 2023 — AccurKardia, an ECG-led diagnostics software company, announced a multi-year agreement with Lucem ...

Home November 21, 2023
Home
News | ECG

October 13, 2023 — InfoBionic, Inc. today announced that it received 510(k) clearance from the U.S. Food and Drug ...

Home October 13, 2023
Home
News | ECG

October 13, 2023 — The newly MDR-certified Cardiomatics solution is accurate, fast and easy-to-use AI-based standalone ...

Home October 13, 2023
Home
News | ECG

September 26, 2023 — Heart Test Laboratories, Inc., an AI-powered medical technology company focused on transforming ...

Home September 26, 2023
Home
News | ECG

September 6, 2023 — Vektor Medical, developer of the only technology to accurately map arrhythmias using just 12-lead ...

Home September 06, 2023
Home
News | ECG

August 15, 2023 — Clario, a healthcare research technology company that delivers leading endpoint technology solutions ...

Home August 15, 2023
Home
News | ECG

July 27, 2023 — Heart Test Laboratories, Inc. d/b/a HeartSciences, an artificial intelligence (AI)-based medical ...

Home July 27, 2023
Home
News | ECG

June 21, 2023 — Anumana, Inc., a leading AI-driven health technology company, has received Breakthrough Device ...

Home June 21, 2023
Home
News | ECG

June 19, 2023 — AliveCor, a global leader in personal electrocardiogram (ECG) technology, has announced a groundbreaking ...

Home June 19, 2023
Home
News | ECG

June 9, 2023 — Mount Sinai researchers have developed an innovative artificial intelligence (AI) model for ...

Home June 09, 2023
Home
Subscribe Now